Eosinophilic pneumonia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
==Epidemiology and Demographics==
==Epidemiology and Demographics==
* IAEP occurs acutely in previously healthy young adults, with a mean age of approximately 30 years, and with male predominance.48–53 Two-thirds of patients are smokers, but there is usually no history of asthma.
* The disease can be triggered by various respiratory exposures, especially a recent initiation of tobacco smoking (as in military or new college student settings52).
* A change in smoking habits,53,54 smoking large quantities of cigarettes (or cigars), reintroduction to smoking (“rechallenge”),50,53–62 or even short-term passive smoking54,63 also can trigger IAEP. A variety of nonspecific environmental inhaled contaminants also have been demonstrated to induce IAEP.1
* Whether this condition should be termed “idiopathic” acute eosinophilic pneumonia in cases clearly related to tobacco smoking or other exposures is debatable.4
* The incidence of CEP in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004 [3].
* The incidence of CEP in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004 [3].
* In registries of interstitial lung disease (ILD) in Europe, CEP accounted for 0 to 2.5 percent of cases of ILD [4].  
* In registries of interstitial lung disease (ILD) in Europe, CEP accounted for 0 to 2.5 percent of cases of ILD [4].  

Revision as of 20:19, 9 February 2018

Pneumonia Main Page

Eosinophilic pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eosinophilic pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Eosinophilic pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eosinophilic pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eosinophilic pneumonia epidemiology and demographics

CDC onEosinophilic pneumonia epidemiology and demographics

Eosinophilic pneumonia epidemiology and demographics in the news

Blogs on Eosinophilic pneumonia epidemiology and demographics

Directions to Hospitals Treating Eosinophilic pneumonia

Risk calculators and risk factors for Eosinophilic pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

  • IAEP occurs acutely in previously healthy young adults, with a mean age of approximately 30 years, and with male predominance.48–53 Two-thirds of patients are smokers, but there is usually no history of asthma.
  • The disease can be triggered by various respiratory exposures, especially a recent initiation of tobacco smoking (as in military or new college student settings52).
  • A change in smoking habits,53,54 smoking large quantities of cigarettes (or cigars), reintroduction to smoking (“rechallenge”),50,53–62 or even short-term passive smoking54,63 also can trigger IAEP. A variety of nonspecific environmental inhaled contaminants also have been demonstrated to induce IAEP.1
  • Whether this condition should be termed “idiopathic” acute eosinophilic pneumonia in cases clearly related to tobacco smoking or other exposures is debatable.4
  • The incidence of CEP in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004 [3].
  • In registries of interstitial lung disease (ILD) in Europe, CEP accounted for 0 to 2.5 percent of cases of ILD [4].
  • A majority of patients are nonsmokers.
  • ICEP is a rare disorder. Its exact prevalence remains unknown.
  • ICEP has been reported to contribute to 0– 2.5% of cases included in different registries of interstitial lung diseases [1].
  • ICEP may affect every age group but is extremely rare in childhood [2-5].
  • It is twice as frequent in women as in men [2,3,6,7].
  • One third to one half of the ICEP patients have a history of asthma [7-12];
  • less than 10% are active smokers [2,3,7].
  • It has recently been reported that ICEP may be primed by radiation therapy for breast cancer [13].

References

Template:WH Template:WS